Abiopharma

Meet the SWE Entrepreneurs Affinity Group Leadership Team — Part 1

ENPH Deadline: Rosen Law Firm Urges Enphase Energy, Inc. (NASDAQ: ENPH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases

Nuvaxovid™ COVID-19 Vaccine Showed Better Tolerability than mNEXSPIKE in Head-to-head Sanofi-led Phase 4 Study

Kaskela Law Firm Announces Stockholder Investigation of HF Foods Group Inc. (HFFG) and Encourages HFFG Shareholders with Investment Losses to Contact the Firm

Press Release: ESCMID: Sanofis Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe

Other Report or Announcement

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP